The development of cardiac resynchronization therapy (CRT) has been crucial in reducing
morbidity and mortality in patients with advanced heart failure. However, a significant …

Cardiac resynchronization therapy (CRT) improves functional status in selected groups of
patients with heart failure and has achieved widespread use. However, approximately one …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Existing knowledge of implantation techniques, advances in device …

Despite improved understanding of heart failure (HF) and advances in medical treatments,
its prevalence continues to rise, and the role of implantable devices continues to evolve …

Cardiac resynchronization therapy (CRT) has become a mainstay therapy to improve clinical
outcomes of patients with left ventricular systolic dysfunction and a wide QRS complex, in …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Cumulated knowledge on the pathophysiological mechanisms …

Patients with advanced heart failure have a high mortality and morbidity despite medical
therapy. Depending on the underlying heart disease and severity of heart failure, 3.7 to …

Cardiac resynchronization therapy (CRT) has shown a substantial reduction in heart failure
patient morbidity and mortality, with improvement in quality of life as well as symptoms. The …

Heart failure (HF) continues to grow and affect more than five million people in the USA. One
of the leading device therapies in HF is cardiac resynchronization therapy (CRT) which has …

Cardiac Resynchronization Therapy continues to evolve at a rapid pace. Growing clinical
experience and additional clinical trials are resulting in changes in how patients are …